Mechanistically, ACE2 exhibits a distinctive transcription signature concerning tumor immune infiltration (TIL) markers, encompassing pro-tumorigenic and anti-tumorigenic facets within each molecular breast cancer subtype. This evidence concerns the gene ACE2 and breast carcinoma.